Skip to Main Content

Steven Schiff

Harvey and Kate Cushing Professor of Neurosurgery, Vice Chair for Global Health, Department of Neurosurgery, Professor of Epidemiology, Department of Epidemiology of Microbial Diseases; Affiliated Faculty, Yale Institute for Global Health; Affiliated Faculty, Yale Program for Biomedical Ethics; Affiliated Faculty, Yale Interdepartmental Program in Neuroscience; Member, Yale Center for Brain and Mind Health

Contact Information

Steven Schiff, MD, PhD, FACS

Mailing Address

  • Neurosurgery

    333 Cedar Street, TMP 413

    New Haven, Connecticut 06510

    United States



Dr. Steven Schiff is a pediatric neurosurgeon with interests in neural control engineering, sustainable health engineering and global health. He founded the Center for Neural Engineering at Penn State University, wrote the first book on Neural Control Engineering (MIT Press, 2012), and is now developing the Center for Global Neurosurgery at Yale University. He received the NIH Director’s Pioneer and Transformative Awards in 2015 and 2018, respectively, which have enabled him to pursue his interests in the sustainable control of infant infections in the developing world. This work has evolved into an exploration of what Schiff calls Predictive Personalized Public Health (P3H), and included leading the discovery of a new highly lethal infant brain disease in Africa - Neonatal Paenibacilliosis.

Education & Training

  • Pediatric Neurosurgery Fellowship
    Children's Hospital of Philadelphia (1990)
  • Neurosurgery Residency
    Duke University (1989)
  • PhD
    Duke University, Physiology (1985)
  • General Surgery Internship
    Duke University (1981)
  • MD
    Duke University (1980)


  • Endoscopic versus Shunt Treatment of Hydrocephalus in Infants (ESTHI). registration NCT04177914.
    New Haven, CT, United States 2019
    North American randomized clinical trial of shunt vs endoscopic treatment of hydrocephalus of infancy.
  • Improving Infant Hydrocephalus Outcomes In Uganda: Predicting Developmental Outcomes And Identifying Patients At Risk For Early Treatment Failure After ETV/CPC
    Mbale, Eastern Region, Uganda 2018
    Study of brain oxygenation and blood flow in hydrocephalus.
  • Personalized Predictive Public Health (P3H)
    Mbale, Eastern Region, Uganda; Mbarara, Western Region, Uganda; Kampala, Central Region, Uganda; Hanoi, Hanoi, Vietnam 2018
    Optimizing treatment and prevention of infant infections in Uganda.
  • Neurocognitive outcomes and changes in brain and CSF volume after treatment of post-infectious hydrocephalus in Ugandan infants by shunting or ETV/CPC: a randomized prospective trial. registration number NCT01936272.
    Mbale, Eastern Region, Uganda 2012
    A randomized trial of shunt versus endoscopic treatment of postinfectious hydrocephalus of infancy in Uganda.

Honors & Recognition

AwardAwarding OrganizationDate
NIH Director’s Transformative Award2018
Honorary African Name: Musaazi, Fumbe Clan2018
FellowAmerican Epilepsy Society2016
NIH Director’s Pioneer Award2015
FellowAmerican Association for the Advancement of Science2012
FellowAmerican Association of Neurological Surgeons2010
FellowAmerican Physical Society2005
FellowAmerican College of Surgeons1994
Diplomat of the American Board of Neurological Surgery1992

Professional Service

AANS/CNS Joint Section on Pediatric Neurosurgery Executive CommitteeResearch Officer of the Chair’s Committee on Planning and Development2021 - Present
Scientific Advisory Board, Institut de Neurosciences des Systèmes, Marseilles, FranceMember2019 - Present
Neural ComputationAssociate Editor2015 - Present
US Food and Drug AdministrationNeurological Devices Panel, Medical Devices Advisory Committee2013 - Present
Journal of Neural EngineeringEditorial Board Member2013 - Present
Physical Review XEditorial Board Member2012 - 2018
Journal of Computational NeuroscienceAction Editor2006 - Present
Physical Review LettersDivisional Associate Editor2006 - 2012
Physical Review EEditorial Board Member2000 - 2005

Departments & Organizations